Composition, purity and perceived quality of street cocaine in France

International Journal of Drug Policy

Volumn 21, Issue 5, 2010, Pages 399-406

  Evrard, Isabelle ^a   Legleye, Stéphane ^a,b,c   Cadet Taïrou, Agnès ^a  

^a French Monitoring Centre for Drugs and Drug Addiction   (France)

^b INSTITUT NATIONAL D'ÉTUDES DÉMOGRAPHIQUES   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Composition; Mode of administration; Perceived quality; Purity; Street cocaine

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETYLSALICYLIC ACID; BUPRENORPHINE; CAFFEINE; COCAINE; CODEINE; DEXTROPROPOXYPHENE; DILTIAZEM; HYDROXYZINE; LEVAMISOLE; LIDOCAINE; PARACETAMOL; PHENACETIN; PHENMETRAZINE; STRYCHNINE;

ADULT; ARTICLE; CHEMICAL COMPOSITION; COCAINE DEPENDENCE; DRUG COST; DRUG PURITY; DRUG QUALITY; FEMALE; FRANCE; HUMAN; INTERVIEW; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; TOXICITY TESTING;

ACETAMINOPHEN; ADOLESCENT; ADULT; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; DATA COLLECTION; DILTIAZEM; DRUG CONTAMINATION; DRUG USERS; FEMALE; FRANCE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; SMOKING; STREET DRUGS; YOUNG ADULT;

EID: 77955845875     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2010.03.004     Document Type: Article

References (52)

1. Akaike H. A new look at statistical model identification. IEEE Transactions on automatic control 1974, 19(6):716-723.
2. Ansah T.A., Wade L.H., Shockley D.C. Effects of calcium channel entry blockers on cocaine and amphetamine-induced motor activities and toxicities. Life Sciences 1993, 53(26):1947-1956.
3. Beck, F., Legleye, S., Spilka, S., Briffault, X., Gautier, A., Lamboy, B., et al. (2006). Les niveaux d'usage des drogues en France en 2005. Exploitation des données du Baromètre santé 2005 relatives aux pratiques d'usage de substances psychoactives en population adulte. Tendances (48), p. 6.
4. Bickel W.K., Marsch L.A. Toward a behavioral economic understanding of drug dependence: Delay discounting processes. Addiction 2001, 96(1):73-86.
5. Boermans P., Go H., Wessels A., Uges D. Quantification by HPLC-MS/MS of atropine in human serum and clinical presentation of six mild-to-moderate intoxicated atropine-adulterated-cocaine users. Therapeutic Drug Monitoring 2006, 28(3):295-298.
6. Brunt T., Rigter S., Hoek J., Vogels N., van Dijk P., Niesink R. An analysis of cocaine powder in the Netherlands: Content and health hazards due to adulterants. Addiction 2009, 104(5):798-805.
7. Buchanan D., Tooze J.A., Shaw S., Kinzly M., Heimer R., Singer M. Demographic, HIV risk behavior, and health status characteristics of " crack" cocaine injectors compared to other injection drug users in three New England cities. Drug and Alcohol Dependence 2006, 81(3):221-229.
8. Cadet-Taïrou A., Gandilhon M., Toufik A., Evrard I. The eighth national report from the TREND system 2008, OFDT, Saint-Denis.
9. Cadet-Taïrou A., Gandilhon M., Toufik A., Evrard I. Phénomènes émergents liés aux drogues en 2006 [Emerging phenomena related to drugs in 2006] 2008, OFDT, Saint-Denis.
10. Casale J.F., Klein R.F.X. Illicit production of cocaine. Forensic Science Review 1993, (5):95-107.
11. Casale J., Corbeil E., Hays P. Identification of levamisole impurities found in illicit cocaine exhibits. Microgram Journal 2008, 6(3-4):82-89.
12. Casale J.F., Boudreau D.K., Jones L.M. Tropane ethyl esters in illicit cocaine: Isolation, detection, and determination of new manufacturing by-products from the clandestine purification of crude cocaine base with ethanol. Journal of Forensic Sciences 2008, 53(3):661-667.
13. Caulkins J.P. Price and purity analysis for illicit drug: Data and conceptual issues. Drug and Alcohol Dependence 2007, 90(Suppl. 1):S61-68.
14. Caulkins J.P., Reuter P. Setting goals for drug policy: Harm reduction or use reduction?. Addiction 1997, 92(9):1143-1150.
15. Coomber R. Adulteration of drugs: The discovery of a myth. Contemporary Drug Problems 1997, 24(2):239-271.
16. Coomber R. The adulteration of drugs: What dealers do, what dealers think. Addiction Research 1997, 5(4):297-306.
17. Decorte T. Quality control by cocaine users: Underdeveloped harm reduction strategies. European Addiction Research 2001, 7(4):161-175.
18. Derlet R.W., Albertson T.E., Tharratt R.S. Lidocaine potentiation of cocaine toxicity. Annals of Emergency Medicine 1991, 20(2):135-138.
19. DGS. (2008). Note d'information sur les risques sanitaires liés à la présence de phénacétine en tant que produit de coupe de la cocaïne [Information and warning about the risks due to phenacetin used as cutting agent in cocaine].
20. EMCDDA Purity of cocaine products at retail level 2006 2006, EMCDDA, Lisbon.
21. EMCDDA Cocaine and crack cocaine: A growing public health issue 2007, European monitoring center for drug and drug addiction, Lisbon.
22. EMCDDA The state of the drugs problem in Europe. Annual report 2008 2008, EMCDDA, Lisbon.
23. Fucci N. Unusual adulterants in cocaine seizured on Italian clandestine market. Forensic Science International 2007, 172(2-3):e1.
24. Fucci N., De Giovanni N. Adulterants encountered in the illicit cocaine market. Forensic Science International 1998, 95(3):247-252.
25. Goudie A.J., Sumnall H.R., Field M., Clayton H., Cole J.C. The effects of price and perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases. Drug and Alcohol Dependence 2007, 89(2-3):107-115.
26. Griffiths P., Vingoe L., Hunt N., Mounteney J., Hartnoll R. Drug information systems. Early warning, and new drug trends: Can drug monitoring systems become more sensitive to emerging trends in drug consumption?. Substance Use and Misuse 2000, 35(6-8):811-844.
27. Hoffman R.S., Kirrane B.M., Marcus S.M. A descriptive study of an outbreak of clenbuterol-containing heroin. Annals of Emergency Medicine 2008, 52(5):548-553.
28. Johnson B.D., Golub A. The potential for accurately measuring behavioral and economic dimensions of consumption, prices, and markets for illegal drugs. Drug and Alcohol Dependence 2007, 90(Suppl. 1):S16-26.
29. Kenyon S.L., Ramsey J., Lee T., Johnston A., Holt D. Analysis for identification in amnesty bin samples from dance venues. Therapeutic Drug Monitoring 2005, 27(6):793-798.
30. King L.A. Drug content of powder and other illicit preparations in the UK. Forensic Science International 1997, (85):135-147.
31. Kinzie E. Levamisole found in patients using cocaine. Annals of Emerging Medicine 2009, 53(4):546-547.
32. Kort P.M., Caulkins J.P., Hartl R.F., Feichtinger G. Brand image and brand dilution in the fashion industry. Automatica 2006, 42(8):1363-1370.
33. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33(1):159-174.
34. Legleye, S., Spilka, S., Le Nézet, O., & Laffiteau, C. (2009). Les drogues à 17 ans - Résultats de l'enquête ESCAPAD 2008 [Drug use of the 17 years old - Results of the 2008 ESCAPAD Survey]. Tendances(66).
35. Lloyd-Smith E., Wood E., Li K., Montaner J.S., Kerr T. Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors. Drug and Alcohol Dependence 2009, 99(1-3):176-182.
36. Lombard J., Levin J., Weiner W. Arsenic intoxication in a cocaine abuser. New England Journal of Medicine 1989, (320):869-1869.
37. Morley S., Forrest A., Galloway J. Levamisole as a contaminant of illicit cocaine. Journal of Clandestine Laboratory Investigating Chemists Association 2006, 16(4):11.
38. Musset, T., Fathi, M., Magnin, A., & Mani, C. (2005). Analyses chimiques d'échantillons d'héroïne et de cocaïne consommés dans les rues de Genève [Chemical analyses of street heroine and cocaine in Genova]. Dépendances.
39. Musto D. The American disease: Origins of narcotic control 1987, Oxford University, New York.
40. Nogue S., Sanz P., Munne P., de la Torre R. Acute scopolamine poisoning after sniffing adulterated cocaine. Drug and Alcohol Dependence 1991, (27):115-116.
41. OFDT. (2007). Note d'information SINTES du 21 décembre 2007 sur la phénacétine [Information and warning about the risk due to phenacetin use as cutting agent in cocaine]. Retrieved May 2009.
42. ONDCP The price and purity of illicit drugs: 1981 through the second quarter of 2003 2004, Executive Office of the President, Washington, DC.
43. Quandt C., Sommi R.J., Pipkin T., McCallum M. Differentiation of cocaine toxicity: Role of the toxicology drug screen. Drug intelligence and clinical pharmacy 1988, 22(7-8):582-587.
44. Rowbotham M.C., Hooker W.D., Mendelson J., Jones R.T. Cocaine-calcium channel antagonist interactions. Psychopharmacology (Berl) 1987, 93(2):152-154.
45. SAMSHA. (2009). Nationwide public health alert issued concerning life-threatening risk posed by cocaine laced with veterinary anti-parasite drug. Substance abuse and mental health services administration Retrieved October 2009, from http://www.samsha.gov/newsroom/advisories/090921vet5101.aspx.
46. Schindler C.W., Srihari T.R., Hashim E.K., Steven G.R. Pharmacological mechanisms in cocaine's cardiovascular effects. Drug and Alcohol Dependence 1995, 37(3):183-191.
47. Sefedov R. Early warning system. EMCDDA issues alert on cocaine/atropine intoxication. Drugnet Europe 2005, 50(April-June):6.
48. Shane D., Kaye S., Libby T. Cocaine use in New South Wales. Australia, 1996-2000: 5-year monitoring of trends in price, purity, availability and use from the illicit drug reporting system. Drug and Alcohol Dependence 2002, 67(1):81-88.
49. Simonsen K.W., Kaa E., Rolmann D.N. Narcotics at street level in Denmark a prospective investigation from 1995 to 2000. Forensic Science International 2003, (131):162-170.
50. Vroegop M., Franssen E., van der Voort P., van der Berg T., Langeweg R., Kramers C. The emergency care of cocaine intoxications. The Netherlands Journal of Medicine 2009, 67(4):122-126.
51. Weiner A.L., Bayer M.J., MacKay C.A.J., Demeo M., Starr E. Anticholinergic poisoning with adulterated intranasal cocaine. The American Journal of Emergency Medicine 1998, 16(5):517-520.
52. Zhu N., Le Gatt D., Turner A. Agranulocytosis after consumption of cocaine adulterant with levamisole. Annals of Internal Medicine 2009, 150(4):287-289.